Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase

BACKGROUND: Clozapine, an atypical antipsychotic medication, has been effectively used to treat refractory schizophrenia. However, the clinical usage of clozapine is limited due to a high incidence of neutropenia or agranulocytosis. We previously reported that clozapine protected dopaminergic neuron...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lulu, Wu, Xuefei, Wang, Shuo, Chen, Shih-Heng, Zhou, Hui, Wilson, Belinda, Jin, Chun-Yang, Lu, Ru-Band, Xie, Keqin, Wang, Qingshan, Hong, Jau-Shyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869380/
https://www.ncbi.nlm.nih.gov/pubmed/27184631
http://dx.doi.org/10.1186/s12974-016-0573-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869380/
https://www.ncbi.nlm.nih.gov/pubmed/27184631
http://dx.doi.org/10.1186/s12974-016-0573-z

Ejemplares similares